While senescence‐linked inflammatory phenotypes caused by classical cancer drugs can be pro‐tumorigenic, senescence induced by CDK4/6 inhibitors lacks NF‐kB‐associated secretory phenotypes and is well tolerated in vivo. The gene discussed is CDK4; the disease is cancer.